ACLY is the novel signaling target of PIP2/PIP3 and Lyn in acute myeloid leukemia.
Basappa J, Citir M, Zhang Q, Wang HY, Liu X, Melnikov O, Yahya H, Stein F, Muller R, Traynor-Kaplan A, Schultz C, Wasik MA, Ptasznik A.
Basappa J, et al. Among authors: ptasznik a.
Heliyon. 2020 May 7;6(5):e03910. doi: 10.1016/j.heliyon.2020.e03910. eCollection 2020 May.
Heliyon. 2020.
PMID: 32420483
Free PMC article.